OREM, Utah, Feb. 19, 2026 /PRNewswire/ — Dymicron®, a privately held medical device company advancing next-generation spinal motion-preservation technology, today announced the appointment of Peter Wehrly, one of the spinal industry’s most seasoned C-suite executives, to its Board of Directors. Mr. Wehrly brings more than forty years of leadership experience, including roles as CEO, President, Chairman, and global P&L leader across multibillion-dollar medical technology organizations. His appointment represents a significant strategic milestone for Dymicron as it progresses the Triadyme-C® cervical disc through its U.S. PMA pathway and expands international commercialization.
19
Feb
